RE:RE:NMIBCChaching, u think pharma doesnt know that!!!!! ?? Only us schmucks have figured that out?????? Seek a jv and ALL OUR PROBLEMS ARE SOLVED TOMORROW, NOT IN TWO OR THREE YEARS LIKE THE CHOIR IS TRYING TO MAKE U BELIEVE SO THEY CAN GET ONE MORE PP THROUGH US!!!! quote=Quattro74]Yes, and nmibc is very lucrative indication for TLT to start. It's been estimated that we will cut the cost of treatments to these patients in half and still make billions $$ each year. That is before we get upgraded to supplant BCG. Insurance companies will love how much less bladder cancer will cost.
enriquesuave wrote: As long as safety continues to be met in this PH1, there should be no reason to stop here and focus on another indication as some here are trying hard to scare people. So far No other cancer treatment has 100% no recurrence at 3 months like we have so far with TLD-1433. Good competing drugs which require many many more treatment sessions only show about 40% no recurrence at 3 months. IMHO 2-3 treatments of TLD-1433 will be what it takes for patients to remain tumor free long term and have an immune response which will prevent further recurrence and progression to the muscle layer. Unheard of kind of results so far for these hard to treat BCG failed patients. And yes GBM and Lung are next IMHO.
[/quote]